In the quest for firmer, more youthful skin, two ingredients dominate the conversation: Retinol and Copper Peptides (GHK-Cu)
When levels drop, the immune system loses some of its responsiveness
Ianalumab, a fully human monoclonal antibody targeting BAFF-R, is under investigation in a randomized, double-blind phase III trial to assess its efficacy and safety in SLE patients (ClinicalTrials.gov Identifier: NCT05624749) (137)
However, no clinical trials have specifically evaluated the safety or efficacy of concurrent creatine and tirzepatide use
It may also increase the risk of subclinical nutritional deficiencies
GHK-Cu is used in laboratory studies to examine peptide-copper interactions, extracellular-matrix-related pathways, and cellular-response behavior in controlled experimental systems